Endocrine diseases have a considerable impact on public health from an epidemiological
point of view and because they may cause long-term disability, alteration of the quality-of-life …

Abstract Purpose of Review The field of neuroendocrine oncology has changed much since
the time of Oberndorfer first described and coined the term carcinoid. The purpose of this …

PURPOSE To develop recommendations for systemic therapy for well-differentiated grade 1
(G1) to grade 3 (G3) metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) …

Neuroendocrine tumors (NETs) express somatostatin receptors (SSTRs) 2 and 5. Modified
variants of somatostatin, the cognate ligand for SSTR2 and SSTR5, are used in treatment for …

ABSTRACT Introduction Neuroendocrine tumors (NETs) are a diverse group of tumors with
origins from different primary sites such as gastro-entero-pancreatic, lung and endocrine …

Background: Somatostatin analog therapies showed great potential for patients suffering
advanced neuroendocrine tumors (NETs). This study was aimed to evaluate the therapeutic …

Background: Neuroendocrine neoplasms (NENs) are rare tumors characterized by variable
biology and delayed diagnosis. However, the nationwide epidemiology of NENs has never …

Cancer is a great equalizer; it does not differentiate between rich or poor, young or old. The
history of cancer is as ancient as the origins of humans and continues to be an enigma in the …

Extracellular vesicles (EVs), such as exosomes or oncosomes, often carry oncogenic
molecules derived from tumor cells. In addition, accumulating evidence indicates that tumor …

The present study aimed to assess gadoxetate disodium contrast‐enhanced (CE) positron
emission tomography (PET)/magnetic resonance imaging (MRI) with 68Ga‐DOTATOC and …